BVXP.L

Bioventix PLC [BVXP.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BVXP.L Stock Summary

Top 10 Correlated ETFs

BVXP.L

Top 10 Correlated Stocks

BVXP.L

In the News

BVXP.L Financial details

Company Rating
-
Market Cap
240.1M
Income
17.08M
Revenue
26.48M
Book val./share
-
Cash/share
-
Dividend
1.52
Dividend %
0.03%
Employees
12
Optionable
No
Shortable
Yes
Earnings
25 Mar 2024
P/E
62.06
Forward P/E
-
PEG
5.04
P/S
38.96
P/B
19.19
P/C
-
P/FCF
54.74
Quick Ratio
4.76
Current Ratio
10.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.28
EPS next Y
-
EPS next Q
-
EPS this Y
9.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
7.15%
Revenue last 5Y
6.65%
Revenue Q/Q
-3.55%
EPS Q/Q
-13.48%
-
-
-
-
SMA20
-3.14%
SMA50
-13.02%
SMA100
-32.47%
Inst Own
-
Inst Trans
-
ROA
28%
ROE
35%
ROC
0.37%
Gross Margin
93%
Oper. Margin
76%
Profit Margin
63%
Payout
140%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3402.0-5100.0
52W High
-50%
52W Low
-25.04%
RSI
48.59
Rel Volume
0.91
Avg Volume
6.44K
Volume
5.89K
Perf Week
0%
Perf Month
-10.53%
Perf Quarter
-31.54%
Perf Half Y
-21.54%
-
-
-
-
Beta
0.364
-
-
Volatility
37.48%, 114.37%
Prev Close
-0.97%
Price
2550
Change
-1.73%

BVXP.L Financial Performance

BVXP.L Dividend History

BVXP.L Frequently Asked Questions

What is Bioventix PLC stock symbol ?

Bioventix PLC is a GB stock and trading under the symbol BVXP.L

What is Bioventix PLC stock quote today ?

Bioventix PLC stock price is $2550 today.

Is Bioventix PLC stock public?

Yes, Bioventix PLC is a publicly traded company.

Something similar

Top by Market Cap
TL0.DE
AMZN
FB2A.DE
V
NVD.DE
Top Correlated ETFs
INR.DE
EXV9.DE
SC0R.DE
JPXH.PA
Top Correlated Stocks
1525.HK
ALFAA.MX
VCP.L
1176.HK
BRNL.AS
Similar Market Cap
SCCC
CC1.DE
FTG.TO
EWMC
FDT

Company Profile

Healthcare Biotechnology
  • Volume Average 6.44K
  • Market Capitalization 240.1M
  • Employee 12
  • CEO Mr. Peter John Harrison MA
  • Headquarters London,GB
  • IPO Date 2014-04-29
  • Website https://www.bioventix.com

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.